138 related articles for article (PubMed ID: 20085485)
21. A cell-based backup to speed up pandemic influenza vaccine production.
Lee MS; Hu AY
Trends Microbiol; 2012 Mar; 20(3):103-5. PubMed ID: 22257962
[TBL] [Abstract][Full Text] [Related]
22. Animal models for the preclinical evaluation of candidate influenza vaccines.
Bodewes R; Rimmelzwaan GF; Osterhaus AD
Expert Rev Vaccines; 2010 Jan; 9(1):59-72. PubMed ID: 20021306
[TBL] [Abstract][Full Text] [Related]
23. Influenza virus: a master of metamorphosis.
De Jong JC; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
J Infect; 2000 May; 40(3):218-28. PubMed ID: 10908015
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of seasonal, avian and pandemic influenza.
J Indian Med Assoc; 2009 Aug; 107(8):506-7. PubMed ID: 20112827
[No Abstract] [Full Text] [Related]
25. Progress with human H5N1 vaccines: a perspective from industry.
Palache B; Krause R
Expert Rev Vaccines; 2009 Apr; 8(4):391-400. PubMed ID: 19348556
[TBL] [Abstract][Full Text] [Related]
26. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E
Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997
[TBL] [Abstract][Full Text] [Related]
27. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
28. Are we ready for pandemic influenza H5N1?
Stephenson I
Expert Rev Vaccines; 2005 Apr; 4(2):151-5. PubMed ID: 15889987
[TBL] [Abstract][Full Text] [Related]
29. Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses.
Jin H; Chen Z
Curr Opin Virol; 2014 Jun; 6():34-9. PubMed ID: 24705137
[TBL] [Abstract][Full Text] [Related]
30. [Role of antineuraminidase antibodies in protection against influenza].
Aymard M; Gerentes L; Kessler N
Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
[TBL] [Abstract][Full Text] [Related]
31. Developing vaccines against pandemic influenza.
Wood JM
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1953-60. PubMed ID: 11779397
[TBL] [Abstract][Full Text] [Related]
32. Development of a vaccine against pandemic influenza viruses: current status and perspectives.
Ilyinskii PO; Thoidis G; Shneider AM
Int Rev Immunol; 2008; 27(6):392-426. PubMed ID: 19065349
[TBL] [Abstract][Full Text] [Related]
33. NEW technologies for meeting the global demand for pandemic influenza vaccines.
Fedson DS
Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
[TBL] [Abstract][Full Text] [Related]
34. Cell-based vaccines yield only modest advances for seasonal flu.
Willyard C
Nat Med; 2013 Jan; 19(1):4. PubMed ID: 23295991
[No Abstract] [Full Text] [Related]
35. Testing of diagnostic methods for detection of influenza virus for optimal performance in the context of an influenza surveillance network.
Pérez-Ruiz M; Yeste R; Ruiz-Pérez MJ; Ruiz-Bravo A; de la Rosa-Fraile M; Navarro-Marí JM
J Clin Microbiol; 2007 Sep; 45(9):3109-10. PubMed ID: 17652478
[TBL] [Abstract][Full Text] [Related]
36. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
O'Hagan DT
Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
[TBL] [Abstract][Full Text] [Related]
37. Current and emerging cell culture manufacturing technologies for influenza vaccines.
Milián E; Kamen AA
Biomed Res Int; 2015; 2015():504831. PubMed ID: 25815321
[TBL] [Abstract][Full Text] [Related]
38. The future of cell culture-based influenza vaccine production.
Perdue ML; Arnold F; Li S; Donabedian A; Cioce V; Warf T; Huebner R
Expert Rev Vaccines; 2011 Aug; 10(8):1183-94. PubMed ID: 21854311
[TBL] [Abstract][Full Text] [Related]
39. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.
Minor PD; Engelhardt OG; Wood JM; Robertson JS; Blayer S; Colegate T; Fabry L; Heldens JG; Kino Y; Kistner O; Kompier R; Makizumi K; Medema J; Mimori S; Ryan D; Schwartz R; Smith JS; Sugawara K; Trusheim H; Tsai TF; Krause R
Vaccine; 2009 May; 27(22):2907-13. PubMed ID: 19366582
[TBL] [Abstract][Full Text] [Related]
40. Influenza vaccines.
Webby RJ; Sandbulte MR
Front Biosci; 2008 May; 13():4912-24. PubMed ID: 18508556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
